Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Other Accumulated Expenses: 2010-2025

Historic Other Accumulated Expenses for Argan (AGX) over the last 5 years, with Jan 2025 value amounting to $19.2 million.

  • Argan's Other Accumulated Expenses fell 40.81% to $7.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $7.5 million, marking a year-over-year decrease of 40.81%. This contributed to the annual value of $19.2 million for FY2025, which is 122.06% up from last year.
  • Per Argan's latest filing, its Other Accumulated Expenses stood at $19.2 million for FY2025, which was up 122.06% from $8.7 million recorded in FY2024.
  • Argan's 5-year Other Accumulated Expenses high stood at $19.2 million for FY2025, and its period low was $8.7 million during FY2024.
  • Over the past 3 years, Argan's median Other Accumulated Expenses value was $12.6 million (recorded in 2023), while the average stood at $13.5 million.
  • In the last 5 years, Argan's Other Accumulated Expenses plummeted by 31.13% in 2024 and then surged by 122.06% in 2025.
  • Over the past 4 years, Argan's Other Accumulated Expenses (Yearly) stood at $13.4 million in 2022, then declined by 6.31% to $12.6 million in 2023, then slumped by 31.13% to $8.7 million in 2024, then surged by 122.06% to $19.2 million in 2025.